BCA
BVS icon

Buckley Capital Advisors’s Bioventus BVS Stock Holding History

Buckley Capital Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$556K Sell
58,900
-22,898
-28% -$219K 0.34% 14
2026
Q1 		$747K Sell
81,798
-322,871
-80% -$2.71M 0.54% 15
2025
Q4 		$3.01M Buy
+404,669
New +$2.91M 2.12% 15

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Buckley Capital Advisors's BVS Position: Q2 2026 in Review

Buckley Capital Advisors reduced its Bioventus (BVS) stake by 28% in Q2 2026, selling an estimated $219K and leaving 58,900 shares worth $556K. The position accounts for 0.34% of the portfolio, ranked #14.

Buckley Capital Advisors first reported a position in BVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.01M in Q4 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Buckley Capital Advisors held 58,900 shares of Bioventus worth $556K as of Q2 2026.
  • Buckley Capital Advisors sold 22,898 Bioventus shares in Q2 2026, an estimated $219K.
  • Bioventus made up 0.34% of Buckley Capital Advisors's portfolio in Q2 2026, its #14 holding.
  • Buckley Capital Advisors first reported a position in Bioventus in Q4 2025 and has held it in 3 quarters since.
  • Buckley Capital Advisors's Bioventus position peaked at $3.01M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Buckley Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.